ZUH.TO BMO Equal Weight US Health Care Hedged to CAD Index ETF
Issuer
BMO
Inception
May 19, 2010
AUM
C$197.5M
Expense ratio
0.39%
Yield
0.46%
Asset class
Equity
Holdings
0
Last price
C$83.45
This exchange-traded fund aims to mirror the performance of the Solactive Equal Weight US Health Care Index Canadian Dollar Hedged, after accounting for its operating costs. It achieves this by acquiring and maintaining holdings in the individual securities that constitute the benchmark index, ensuring they reflect the same proportional weighting. Furthermore, the fund actively manages its US dollar exposure by converting it back to Canadian dollars, effectively mitigating currency fluctuations for investors.
+21.9%
2025-11-13low 64.10 · high 85.452026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| ZUH.TO | +6.5% | +8.6% | +20.1% | +22.5% | +11.1% | +0.0% |
| Equity average (793 funds) | +0.2% | -0.5% | +8.4% | +10.1% | +12.0% | +5.7% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$14K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| MDGL Madrigal Pharmaceuticals, Inc. | 0.85% | $35.0M | $7.0M |
| COO The Cooper Companies, Inc. | 0.96% | $1.9M | $0 |
| ELAN Elanco Animal Health Incorporated | 1.14% | $1.0M | $100K |
| ALNY Alnylam Pharmaceuticals, Inc. | 0.64% | $543K | $399K |
| PODD Insulet Corporation | 1.08% | $162K | $0 |
| BSX Boston Scientific Corporation | 1.00% | $100K | $0 |
| CRL Charles River Laboratories International, Inc. | 1.26% | $3K | $20.3M |
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | MRNA Moderna, Inc. | 1.81% |
| 2 | GKOS Glaukos Corporation | 1.47% |
| 3 | IDXX IDEXX Laboratories, Inc. | 1.39% |
| 4 | MTD Mettler-Toledo International Inc. | 1.38% |
| 5 | LLY Eli Lilly and Company | 1.32% |
| 6 | HCA HCA Healthcare, Inc. | 1.32% |
| 7 | VTRS Viatris Inc. | 1.32% |
| 8 | TEM Tempus AI, Inc. | 1.30% |
| 9 | ISRG Intuitive Surgical, Inc. | 1.30% |
| 10 | UTHR United Therapeutics Corporation | 1.29% |
| 11 | RVTY Revvity, Inc. | 1.29% |
| 12 | WST West Pharmaceutical Services, Inc. | 1.28% |
| 13 | GEHC GE HealthCare Technologies Inc. | 1.27% |
| 14 | EXEL Exelixis, Inc. | 1.27% |
| 15 | BTSG BrightSpring Health Services, Inc. | 1.26% |
| 16 | MCK McKesson Corporation | 1.26% |
| 17 | CRL Charles River Laboratories International, Inc. | 1.26% |
| 18 | EW Edwards Lifesciences Corporation | 1.24% |
| 19 | A Agilent Technologies, Inc. | 1.24% |
| 20 | TMO Thermo Fisher Scientific Inc. | 1.24% |
| 21 | EHC Encompass Health Corporation | 1.24% |
| 22 | BDX Becton, Dickinson and Company | 1.23% |
| 23 | UHS Universal Health Services, Inc. | 1.23% |
| 24 | REGN Regeneron Pharmaceuticals, Inc. | 1.23% |
| 25 | QIA.DE Qiagen N.V. | 1.22% |
| 26 | MDLN MEDLINE INC | 1.22% |
| 27 | ABBV AbbVie Inc. | 1.22% |
| 28 | WAT Waters Corporation | 1.22% |
| 29 | BIIB Biogen Inc. | 1.21% |
| 30 | STE STERIS plc | 1.21% |
| 31 | LH Labcorp Holdings Inc. | 1.20% |
| 32 | DHR Danaher Corporation | 1.20% |
| 33 | MEDP Medpace Holdings, Inc. | 1.19% |
| 34 | GILD Gilead Sciences, Inc. | 1.19% |
| 35 | CAH Cardinal Health, Inc. | 1.19% |
| 36 | NBIX Neurocrine Biosciences, Inc. | 1.19% |
| 37 | HUM Humana Inc. | 1.18% |
| 38 | VEEV Veeva Systems Inc. | 1.17% |
| 39 | THC Tenet Healthcare Corporation | 1.17% |
| 40 | ZBH Zimmer Biomet Holdings, Inc. | 1.16% |
| 41 | RPRX Royalty Pharma plc | 1.16% |
| 42 | DGX Quest Diagnostics Incorporated | 1.15% |
| 43 | ENSG The Ensign Group, Inc. | 1.15% |
| 44 | ZTS Zoetis Inc. | 1.15% |
| 45 | ALGN Align Technology, Inc. | 1.15% |
| 46 | ELAN Elanco Animal Health Incorporated | 1.14% |
| 47 | 0Y6X.L Medtronic plc | 1.14% |
| 48 | AMGN Amgen Inc. | 1.13% |
| 49 | CI The Cigna Group | 1.13% |
| 50 | BBIO BridgeBio Pharma, Inc. | 1.12% |
| 51 | COR Cencora, Inc. | 1.12% |
| 52 | ANTM Elevance Health, Inc. | 1.11% |
| 53 | SYK Stryker Corporation | 1.11% |
| 54 | CNC Centene Corporation | 1.11% |
| 55 | RMD ResMed Inc. | 1.10% |
| 56 | PFE Pfizer Inc. | 1.09% |
| 57 | IQV IQVIA Holdings Inc. | 1.08% |
| 58 | BAX Baxter International Inc. | 1.08% |
| 59 | JNJ Johnson & Johnson | 1.08% |
| 60 | PODD Insulet Corporation | 1.08% |
| 61 | UNH UnitedHealth Group Incorporated | 1.07% |
| 62 | ABT Abbott Laboratories | 1.07% |
| 63 | JAZZ Jazz Pharmaceuticals plc | 1.06% |
| 64 | TECH Bio-Techne Corporation | 1.06% |
| 65 | VRTX Vertex Pharmaceuticals Incorporated | 1.06% |
| 66 | PEN Penumbra, Inc. | 1.06% |
| 67 | DVA DaVita Inc. | 1.05% |
| 68 | HSIC Henry Schein, Inc. | 1.04% |
| 69 | MRK Merck & Co., Inc. | 1.04% |
| 70 | ILMN Illumina, Inc. | 1.03% |
| 71 | NTRA Natera, Inc. | 1.03% |
| 72 | SOLV Solventum Corporation | 1.02% |
| 73 | INCY Incyte Corporation | 1.02% |
| 74 | GH Guardant Health, Inc. | 1.01% |
| 75 | INSM Insmed Incorporated | 1.01% |
| 76 | SMMT Summit Therapeutics Inc. | 1.00% |
| 77 | BSX Boston Scientific Corporation | 1.00% |
| 78 | BMY Bristol-Myers Squibb Company | 1.00% |
| 79 | HALO Halozyme Therapeutics, Inc. | 0.98% |
| 80 | DXCM DexCom, Inc. | 0.97% |
| 81 | COO The Cooper Companies, Inc. | 0.96% |
| 82 | BMRN BioMarin Pharmaceutical Inc. | 0.93% |
| 83 | KRYS Krystal Biotech, Inc. | 0.91% |
| 84 | RVMD Revolution Medicines, Inc. | 0.91% |
| 85 | CYTK Cytokinetics, Incorporated | 0.85% |
| 86 | MDGL Madrigal Pharmaceuticals, Inc. | 0.85% |
| 87 | AXSM Axsome Therapeutics, Inc. | 0.76% |
| 88 | CORT Corcept Therapeutics Incorporated | 0.71% |
| 89 | ALNY Alnylam Pharmaceuticals, Inc. | 0.64% |
| 90 | ARWR Arrowhead Pharmaceuticals, Inc. | 0.60% |
| 91 | IONS Ionis Pharmaceuticals, Inc. | 0.52% |
| 92 | ZUH.TO CONTRA HOLOGIC INCORPO | 0.00% |
Sector breakdown
Healthcare100.0%
Country breakdown
United States100.0%
Distributions
| Date | Per unit |
|---|---|
| Dec 30, 2025 | C$0.3800 |
| Dec 30, 2024 | C$0.4870 |
| Dec 27, 2023 | C$0.5050 |
| Dec 28, 2022 | C$0.3000 |
| Dec 29, 2021 | C$0.1000 |
| Dec 29, 2020 | C$0.2700 |
| Dec 27, 2019 | C$0.2000 |
| Dec 27, 2018 | C$0.1600 |
| Dec 27, 2017 | C$0.1800 |
| Dec 23, 2016 | C$0.1900 |
| Dec 24, 2015 | C$0.2000 |
| Dec 24, 2014 | C$0.5459 |
| Dec 24, 2013 | C$0.1200 |
| Dec 24, 2012 | C$0.1200 |
| Dec 23, 2011 | C$0.1000 |
| Dec 24, 2010 | C$0.0800 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in ZUH.TO in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error